Zacks Investment Research on MSN

Editas (EDIT) up 3.8% since last earnings report: Can it continue?

A month has gone by since the last earnings report for Editas Medicine (EDIT). Shares have added about 3.8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...
Hosted on MSN

Editas Medicine (EDIT) reports Q4 loss, tops revenue estimates

Editas Medicine (EDIT) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.55 per share a year ago. These figures ...